![Cécile Bougeret](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cécile Bougeret
Direttore operativo presso Diaccurate SA
Provenienza dei contatti di primo grado di Cécile Bougeret
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Diaccurate SA
![]() Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France.
8
| Holding Company | Medical Specialties | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Cécile Bougeret tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
AFFLUENT MEDICAL | Medical Specialties | Founder Director/Board Member | |
NEOVACS | Pharmaceuticals: Major | Director/Board Member | |
Caranx Medical SAS | Founder | ||
Baxter Healthcare Corp.
![]() Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Corporate Officer/Principal | |
MABCURE INC | Pharmaceuticals: Major | Director/Board Member | |
Lazard Asset Management LLC
![]() Lazard Asset Management LLC Investment ManagersFinance Lazard Asset Management LLC (LAM) is a SEC-registered investment advisor headquartered in New York City. The firm was founded in 1970 and is a wholly-owned subsidiary of Lazard Frères & Co. LLC, ultimately held by Lazard, Inc. (NYSE: LAZ). LAM manages investment portfolios and provides investment advice to institutional and individual investors around the world. | Investment Managers | Analyst-Equity | |
Spikimm SAS | Chairman | ||
Bariatek Medical SAS | Director/Board Member | ||
Demeta SAS
![]() Demeta SAS BiotechnologyHealth Technology Demeta SAS operates as a research and Development in Biotechnology. The firm specializes in biological products, except diagnostic substances. The company was founded in April 4, 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Pk Med SAS | Chairman | ||
Imperial College London | College/University | Undergraduate Degree | |
Skinosive Sasu | Chairman | ||
Artedrone SAS | Director/Board Member | ||
Holistick Medical Sasu | Director/Board Member | ||
CARBIOS | Miscellaneous Commercial Services | Founder | |
Bmd SA | Chairman | ||
University College London | College/University | Graduate Degree | |
Shanghai Myopowers Medical Technology Co. Ltd. | Director/Board Member | ||
Sibylla Biotech Srl
![]() Sibylla Biotech Srl Internet Software/ServicesTechnology Services Sibylla Biotech Srl engages in research and development activities in the pharmaceutical sector. It specializes in studies through its proprietary atom computer simulations for new drug discoveries. The company was founded by Maria Letizia Barreca and Emiliano Biasini in 2017 and is headquartered in Trento, Italy. | Internet Software/Services | Chairman | |
Hep Industrie SASU
![]() Hep Industrie SASU Trucks/Construction/Farm MachineryProducer Manufacturing Hep Industrie SASU designs and manufactures drill crane pose poles and pulling winches electric or telephone lines. Its products include drilling crane pose poteaux, winches and weighing trailers. The company is headquartered in Semeac, France. | Trucks/Construction/Farm Machinery | Founder | |
Hoechst Marion Roussel Australia Pty Ltd. | Director of Finance/CFO | ||
SANOFI | Pharmaceuticals: Major | Chief Administrative Officer | |
École Nationale Supérieure de Chimie de Paris | College/University | Graduate Degree | |
Université Paris-Saclay | College/University | Doctorate Degree | |
IMMUNE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
NEURONAX SA
![]() NEURONAX SA Pharmaceuticals: MajorHealth Technology NEURONAX SA develops and provides drugs supporting neural repair to treat degenerative disorders of the central nervous system. Its services include cell culture, in vitro evaluation, neurotrophic and neuroprotective effects analysis, culture analyses, and stem cells. The company was founded by Stéphane Gobron, Fabrice Cailloux, and Pierre-Yves Simonin in 2003 and is headquartered in Saint-Beauzire, France. | Pharmaceuticals: Major | Director/Board Member | |
Optivia Biotechnology, Inc.
![]() Optivia Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Optivia Biotechnology, Inc. provides contract research organization offering drug transporter research services and solutions to biotechnology, pharmaceutical and academic organizations. It offers regulatory DDI studies, transporter screening, tranporter profiling, and custom development services. The firm's products include TransFlex Single Transporter Assay Plates,TransFlex Multi-Transporter Model Plates, and Certified Efflux Transporter Vesicles. The company was founded by Yong Huang, Pascal Druzgala and Peter G. Milner in 2007 and is headquartered in Santa Clara, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Tegris Corp. | Corporate Officer/Principal | ||
Genome Profiling LLC
![]() Genome Profiling LLC Packaged SoftwareTechnology Services Genome Profiling LLC provides software platform to discover novel epigenetic biomarkers. The firm offers its services to researchers and clinicians to tailor diagnostics and therapies for the needs of individual patients. The company was founded by Jeb Connor and Adam Marsh and is headquartered in Wayne, PA. | Packaged Software | Director/Board Member | |
EDITAS MEDICINE, INC. | Biotechnology | Corporate Officer/Principal | |
Epivax Oncology, Inc.
![]() Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Biotechnology | Founder | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
Myopowers Medical Technolgies SA, (Zweigniederlassung Basel) | Director/Board Member | ||
Epygon SASU
![]() Epygon SASU Medical SpecialtiesHealth Technology Epygon SASU develops mitral valve instruments. It also engages in the research and development in physical and natural sciences. The company was founded by Marcio Scorsin and Enrico Pasquino on December 28, 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Kardiozis SAS
![]() Kardiozis SAS Medical SpecialtiesHealth Technology Kardiozis SAS engages in radio diagnostic and radiotherapy activities. It also develops aortic stent. The company was founded on March 15, 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member | |
Conseil Stratégique pour l'Innovation | Chairman | ||
Drugabuse Sciences, Inc. | Founder | ||
Sangstat Pharmaceuticals Corp. | Founder | ||
CARMAT | Medical Specialties | Founder | |
PHARNEXT SCA | Biotechnology | Founder | |
Plasmaprime SAS
![]() Plasmaprime SAS Medical/Nursing ServicesHealth Services Plasmaprime SAS provides plasma derived drugs collected from blood transfusion centers. The company was founded by Heriberto Sieler and Philippe Pouletty on January 23, 2009 and is headquartered in Evry, France. | Medical/Nursing Services | Founder | |
DEINOVE | Biotechnology | Founder | |
Wittycell SAS
![]() Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Pharmaceuticals: Major | Founder | |
THERACLION | Medical Specialties | Director/Board Member | |
VEXIM | Medical Specialties | Founder |
Statistiche
Distribuzione geografica
Francia | 31 |
Stati Uniti | 14 |
Regno Unito | 3 |
Argentina | 2 |
Cina | 2 |
Settori
Health Technology | 23 |
Consumer Services | 7 |
Finance | 3 |
Technology Services | 3 |
Commercial Services | 2 |
Posizioni
Director/Board Member | 49 |
Founder | 25 |
Chairman | 15 |
Corporate Officer/Principal | 7 |
Chief Executive Officer | 6 |
Contatti più connessi
- Borsa valori
- Insiders
- Cécile Bougeret
- Connessioni Società